(1.02%) 5 099.96 points
(0.40%) 38 240 points
(2.03%) 15 928 points
(0.11%) $83.66
(-1.16%) $1.619
(0.30%) $2 349.60
(-0.43%) $27.52
(0.42%) $924.40
(0.32%) $0.935
(0.67%) $11.02
(0.13%) $0.800
(-0.07%) $92.11
Live Chart Being Loaded With Signals
Stratec SE, together with its subsidiaries, designs and manufactures automation and instrumentation solutions in the fields of in-vitro diagnostics and life sciences in Germany, European Union, and internationally...
Stats | |
---|---|
Dagens volum | 18 423.00 |
Gjennomsnittsvolum | 8 520.00 |
Markedsverdi | 506.29M |
EPS | €0 ( 2024-03-28 ) |
Neste inntjeningsdato | ( €0 ) 2024-06-07 |
Last Dividend | €0.970 ( 2023-05-18 ) |
Next Dividend | €0 ( N/A ) |
P/E | 38.93 |
ATR14 | €0.187 (0.45%) |
Volum Korrelasjon
Stratec SE Korrelasjon
10 Mest positive korrelasjoner |
---|
10 Mest negative korrelasjoner |
---|
Visste du det?
Korrelasjon er en statistisk måling som beskriver forholdet mellom to variabler. Den varierer fra -1 til 1, hvor -1 indikerer en perfekt negativ korrelasjon (hvor en variabel øker, går den andre ned), 1 indikerer en perfekt positiv korrelasjon (hvor en variabel øker, går den andre også opp), og 0 indikerer ingen korrelasjon (det er ingen forhold mellom variablene).
Korrelasjon kan brukes til å analysere forholdet mellom to variabler, ikke bare aksjer. Det er vanligvis brukt innen områder som finans, økonomi, psykologi, og mer.
Stratec SE Korrelasjon - Valuta/Råvare
Stratec SE Økonomi
Annual | 2023 |
Omsetning: | €261.91M |
Bruttogevinst: | €64.85M (24.76 %) |
EPS: | €1.080 |
FY | 2023 |
Omsetning: | €261.91M |
Bruttogevinst: | €64.85M (24.76 %) |
EPS: | €1.080 |
FY | 2022 |
Omsetning: | €274.63M |
Bruttogevinst: | €79.49M (28.94 %) |
EPS: | €2.41 |
FY | 2021 |
Omsetning: | €287.34M |
Bruttogevinst: | €87.71M (30.53 %) |
EPS: | €3.30 |
Financial Reports:
No articles found.
Stratec SE Dividends
(Q3/22) | (Q4/22) | (Q1/23) | (Q2/23) | (Q3/23) | (Q4/23) | (Q1/24) | (Q2/24) | (Q3/24) | (Q4/24) |
€0 (N/A) |
€0 (N/A) |
€0 (N/A) |
€0.970 (N/A) |
€0 (N/A) |
€0 (N/A) |
€0 (N/A) |
€0 (N/A) |
€0 (N/A) |
€0 (N/A) |
Very Unsafe
High risk of being cut
Unsafe
Heightened risk of being cut
Borderline
Moderate risk of being cut
Safe
Unlikely to be cut
Very Safe
Very unlikely to be cut
First Dividend | €0.0267 | 2004-05-17 |
Last Dividend | €0.970 | 2023-05-18 |
Next Dividend | €0 | N/A |
Payout Date | 0000-00-00 | |
Next Payout Date | N/A | |
# dividends | 20 | -- |
Total Paid Out | €11.02 | -- |
Avg. Dividend % Per Year | 0.00% | -- |
Score | 2.94 | -- |
Div. Sustainability Score | 10.00 | |
Div.Growth Potential Score | 3.98 | |
Div. Directional Score | 7.45 | -- |
Year | Amount | Yield |
---|
The company's strong Dividend Sustainability Score (DSS) indicates its robust capacity to uphold current dividend levels. Unfortunately, its low Dividend Growth Potential Score (DGPS) suggests limited prospects for dividend growth. In summary, the company provides a promising overall dividend outlook, balancing both sustainability and growth potential.
Symbol | Title | Last dividend | Frequency | Years Dividend | Yearly Dividend | Score |
---|---|---|---|---|---|---|
PUM.DE | Ex Dividend Junior | 2023-05-25 | Annually | 0 | 0.00% | |
BMW.DE | Ex Dividend Junior | 2023-05-12 | Annually | 0 | 0.00% | |
INN1.DE | Ex Dividend Junior | 2023-08-07 | Semi-Annually | 0 | 0.00% | |
SWF.DE | Ex Dividend Junior | 2023-09-01 | Quarterly | 0 | 0.00% | |
CVS.DE | Ex Dividend Knight | 2023-10-19 | Quarterly | 0 | 0.00% | |
LUS1.DE | Ex Dividend Junior | 2023-06-23 | Annually | 0 | 0.00% | |
2M6.DE | Ex Dividend Knight | 2023-09-21 | Quarterly | 0 | 0.00% | |
VFP.DE | Ex Dividend Junior | 2023-09-08 | Quarterly | 0 | 0.00% | |
ENI.F | Ex Dividend Knight | 2023-11-20 | Semi-Annually | 0 | 0.00% | |
NVJP.DE | Ex Dividend Knight | 2023-08-18 | Annually | 0 | 0.00% |
Ratio | Actual Value | Weight | Normalized Value | Score | Range |
---|---|---|---|---|---|
netProfitMarginTTM | 0.0499 | 1.500 | 9.00 | 10.00 | [0 - 0.5] |
returnOnAssetsTTM | 0.0272 | 1.200 | 9.09 | 10.00 | [0 - 0.3] |
returnOnEquityTTM | 0.0573 | 1.500 | -0.474 | -0.711 | [0.1 - 1] |
payoutRatioTTM | 0.0000765 | -1.000 | 10.00 | -10.00 | [0 - 1] |
currentRatioTTM | 2.54 | 0.800 | 2.28 | 1.823 | [1 - 3] |
quickRatioTTM | 1.044 | 0.800 | 8.57 | 6.85 | [0.8 - 2.5] |
cashRatioTTM | 0.348 | 1.500 | 9.18 | 10.00 | [0.2 - 2] |
debtRatioTTM | 0.267 | -1.500 | 5.56 | -8.34 | [0 - 0.6] |
interestCoverageTTM | 5.82 | 1.000 | 8.95 | 8.95 | [3 - 30] |
operatingCashFlowPerShareTTM | 1.598 | 2.00 | 9.47 | 10.00 | [0 - 30] |
freeCashFlowPerShareTTM | 0.165 | 2.00 | 9.92 | 10.00 | [0 - 20] |
debtEquityRatioTTM | 0.548 | -1.500 | 7.81 | -10.00 | [0 - 2.5] |
grossProfitMarginTTM | 0.248 | 1.000 | 9.21 | 9.21 | [0.2 - 0.8] |
operatingProfitMarginTTM | 0.0887 | 1.000 | -0.225 | -0.225 | [0.1 - 0.6] |
cashFlowToDebtRatioTTM | 0.152 | 1.000 | -0.267 | -0.267 | [0.2 - 2] |
assetTurnoverTTM | 0.546 | 0.800 | 9.69 | 7.75 | [0.5 - 2] |
Total Score | 10.92 |
Ratio | Actual Value | Weight | Normalized Value | Score | Range |
---|---|---|---|---|---|
peRatioTTM | 38.75 | 1.000 | 6.19 | 0 | [1 - 100] |
returnOnEquityTTM | 0.0573 | 2.50 | -0.305 | -0.711 | [0.1 - 1.5] |
freeCashFlowPerShareTTM | 0.165 | 2.00 | 9.95 | 10.00 | [0 - 30] |
dividendYielPercentageTTM | 2.33 | 1.500 | 10.00 | 0 | [0 - 0.4] |
operatingCashFlowPerShareTTM | 1.598 | 2.00 | 9.47 | 10.00 | [0 - 30] |
payoutRatioTTM | 0.0000765 | 1.500 | 10.00 | -10.00 | [0 - 1] |
pegRatioTTM | 0 | 1.500 | -3.33 | 0 | [0.5 - 2] |
operatingCashFlowSalesRatioTTM | 0.0742 | 1.000 | -0.646 | 0 | [0.1 - 0.5] |
Total Score | 3.98 |
Stratec SE
Stratec SE, together with its subsidiaries, designs and manufactures automation and instrumentation solutions in the fields of in-vitro diagnostics and life sciences in Germany, European Union, and internationally. It operates through three segments: Instrumentation, Diatron, and Smart Consumables. The Instrumentation segment designs and manufactures automated analyzer systems, including service parts and consumables for clinical diagnostics and biotechnology customers. The Diatron segment offers systems, system components, consumables, and tests for the low throughput hematology and clinical chemistry applications. The Smart Consumables segment develops and manufactures smart consumables in the fields of diagnostics, life sciences, and medical technologies. The company was formerly known as STRATEC Biomedical AG and changed its name to Stratec SE in December 2018. Stratec SE was founded in 1979 and is headquartered in Birkenfeld, Germany.
Om Live Signaler
Live Trading signaler pa denne siden er ment til å hjelpe deg i beslutningsprossessen for når du bør KJØPE eller SELGE NA. Signalene har opp mot 1-minutt forsinkelse; som med alle andre indikatorer og signaler, er det en viss sjanse for feil eller feilkalkuleringer.
Live signalene er kun veiledende, og getagraph.com tar ikke noen form for ansvar basert pa handlinger gjort på disse signalene som beskrevet i Terms of Use. Signalene er basert på en rekke indikatorer og påliteligheten vil variere sterke fra aksje til aksje.